Uploaded March 2026 | Updated September 2026, 2 weeks ago
The era of Pharmaceutical Superintelligence has arrived. Join Alex Zhavoronkov (Insilico Medicine) and Ramin Hasani (Liquid AI) for an exclusive fireside chat and live demo of LFM2-2.6B-MMAI.
This 2.6B-parameter scientific foundation model is a game-changer for drug discovery. Trained via the Science MMAI Gym, it delivers state-of-the-art performance in molecular property prediction and ADMET endpoints—all while running locally on-premise.
Why it matters:
Data Sovereignty: High-performance AI that keeps proprietary IP behind your firewall—no cloud transmission required.
Efficiency: Outperforms models 10x its size, reducing compute costs and R&D timelines.
End-to-End Capability: Supports every stage from initial hit discovery to optimization.
#LiquidAI #InsilicoMedicine #Biotech #OnPremiseAI #DrugDiscovery #DeepTech
The era of Pharmaceutical Superintelligence has arrived. Join Alex Zhavoronkov (Insilico Medicine) and Ramin Hasani (Liquid AI) for an exclusive fireside chat and live demo of LFM2-2.6B-MMAI.
This 2.6B-parameter scientific foundation model is a game-changer for drug discovery. Trained via the Science MMAI Gym, it delivers state-of-the-art performance in molecular property prediction and ADMET endpoints—all while running locally on-premise.
Why it matters:
Data Sovereignty: High-performance AI that keeps proprietary IP behind your firewall—no cloud transmission required.
Efficiency: Outperforms models 10x its size, reducing compute costs and R&D timelines.
End-to-End Capability: Supports every stage from initial hit discovery to optimization.
#LiquidAI #InsilicoMedicine #Biotech #OnPremiseAI #DrugDiscovery #DeepTech
